Kimball Electronics (Nasdaq: KE) Acquires European-Based Medical CDMO, Helvoet Polymer Technologies B.V.

Jul 1, 2026, 08:54 by Nicole Krempp

 

 

Kimball Electronics (Nasdaq: KE) today announced the acquisition of Helvoet Polymer Technologies B.V., a Contract Development and Manufacturing Organization (CDMO) based in Europe with operations in India focused on microfluidics, diagnostics, and drug delivery.

The acquisition represents an important step in Kimball Electronics' strategy to expand its CMO capabilities and strengthen its position in the medical industry. Over the past several years, the Company has taken deliberate actions to streamline operations, strengthen its balance sheet, and build a foundation for future growth.

By adding Helvoet's specialized expertise and capabilities, Kimball Electronics expands its global medical manufacturing footprint, enhances its ability to serve healthcare customers, and advances its vision of building a differentiated global medical manufacturing platform. Together, the two organizations will leverage complementary strengths, deepen customer relationships, and pursue new opportunities for long-term growth and value creation.

View Full Press Release

Load more comments
Thank you for the comment! Your comment must be approved first
Comment by from

STAY IN THE LOOP. SIGN UP FOR OUR NEWSLETTER TODAY.